Patent: 8,980,242
✉ Email this page to a colleague
Summary for Patent: 8,980,242
| Title: | Aliphatic prodrug linker |
| Abstract: | A polymeric prodrug is described which comprises at least one polymer attached via at least one permanent bond to a bicine linker. The bicine linker is attached via a temporary linkage to an amine containing biologically active moiety. The amine containing biologically active moiety--such as a drug--can be released by cleaving the temporary linkage. |
| Inventor(s): | Vetter; Dirk (Heidelberg, DE), Rau; Harald (Heidelberg, DE), Wegge; Thomas (Heidelberg, DE), Hersel; Ulrich (Heidelberg, DE) |
| Assignee: | Ascendis Pharma GmbH (Hellerup, DK) |
| Application Number: | 11/993,645 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,980,242
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2025-06-22 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2025-06-22 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2025-06-22 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2025-06-22 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | 03/26/1974 | ⤷ Try a Trial | 2025-06-22 |
| Ferring Pharmaceuticals Inc. | A.P.L. | chorionic gonadotropin | For Injection | 017055 | 12/13/1974 | ⤷ Try a Trial | 2025-06-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
